Metastatic Malignant Neoplasm in the Brain Clinical Trials in Tampa, Florida

3 studies are recruiting for metastatic malignant neoplasm in the brain in Tampa, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

    This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binimetinib may stop the growth of tumor cells by blocking some of…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Moffitt Cancer Center-International Plaza, Tampa, Florida
    Locations
    331 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT04511013 on ClinicalTrials.gov

  2. Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

    This phase IIa trial studies how well dendritic cell vaccines against Her2/Her3 and pembrolizumab work for the treatment of triple negative breast cancer or HER2+ breast cancer or HER+ Breast cancer that has spread to the brain (brain metastasis). Dendritic cell vaccines work by boosting the immune…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Moffitt Cancer Center, Tampa, Florida
    Locations
    3 in total
    Run by
    Roswell Park Cancer Institute

    See if you can join NCT04348747 on ClinicalTrials.gov

  3. S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

    This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (curren…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Moffitt Cancer Center, Tampa, Florida
    Locations
    590 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT03418961 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.